Mag. Julia Tulipan MSc.

It's a big day for the field of Metabolic Psychiatry! Many of you know our origin story--how our son @matthewbaszucki recovered from a five year battle with bipolar disorder using ketogenic and other metabolic therapies. Since then, we've launched @BaszuckiGroup and have backed more than twenty clinical trials of ketogenic therapy for serious mental illness, the first of which are now being published with promising results. We started @Metabolic_Mind to share science, strategies and stories from the field with families like ours. We launched the Coalition for Metabolic Health @metcoalition to advance policy. But there was still a gap. Fourteen months ago, Harvard-trained psychiatrist @GeorgiaEdeMD--one of the founders of the field and a close collaborator of @BaszuckiGroup--came to us with a problem and an opportunity. Her inbox was flooded with messages from practitioners around the world who wanted to be part of the metabolic psychiatry movement. They longed for community and training; they wanted to share what they were learning about using ketogenic and other metabolic therapies to treat and even reverse mental illness and to improve overall well-being in their patients; they wanted to both help and learn from other doctors, nurse practitioners, dieticians, therapists, social workers, health coaches and scientists. Dr. Ede barely had time to reply to all the inquiries; would Baszucki Group step up to help? The answer was a resounding yes. Our dedicated team of scientists, clinicians, program managers, and lived experience experts got right to work. Today, just over a year later, I am thrilled to share that our new initiative--the Global Network for the Advancement of Metabolic Psychiatry (MetPsy) @met_psy--is live! MetPsy is a community of scientists and practitioners dedicated to scaling research, education, and clinical care in metabolic psychiatry worldwide. We launch at a pivotal time. As the field expands, demand for resources has grown among researchers and clinicians, as well as the patients they serve. MetPsy addresses this need by providing a centralized network for professional collaboration, shared resources, access to accredited courses, and tools for advancing clinical practice. Alongside this launch, we've also announced a grant from our family foundation to establish the new McLean Center for Metabolic Psychiatry, a flagship clinical care, research and medical education and training center at @McLeanHospital, a member of Mass General Brigham. Medical education and training initiatives will be co-led by @ChrisPalmerMD's MH² , a clinical practice, training, and education hub. Our prior five years of investments in science, education and clinical care form the foundation for the MetPsy community. It is fitting that this center finds its home in Boston. Along with Stanford, where @ShebaniMD ran the first clinical trial of keto for serious mental illness, Boston has been a birthplace of the field. It was there that pioneering physicians like @GeorgiaEdeMD, @ChrisPalmerMD and @MattBernstein6 (Accord), along with @loricalabresemd in nearby Connecticut, first advanced a new way of understanding and treating mental disorders. Their commitment to the field has helped make this day possible, as has scientific leadership from Harvard and McLean's Dost Unger and Virginie-Anne Chouinard, along with so many others. I want to extend my deepest thanks to the staff at Baszucki Group--especially the MetPsy team led by Executive Director @KirkNylen in close partnership with @julie_milder, Karen Romans and Soly Lee--for the passion and dedication that led to launching this program in record time. As a family, we were blessed with our son's full recovery from what was supposed to be a chronic, lifelong mental illness. Our investment in MetPsy and the new center at McLean is @DavidBaszucki and my way of giving back and offering hope to families like ours. Join the network today!